Dr. Juei-Yu Tseng specializes in the diagnosis and treatment of diabetes, hyperlipidemia, hypertension, and thyroid, parathyroid, adrenal, osteoporosis and pituitary diseases. His clinical and research interests include thyroid diseases, radiofrequency ablation of thyroid nodules, and alcohol injection therapy. In November 2024, he studied radiofrequency ablation of thyroid nodules at Asan Medical Center in South Korea.

Dr. Yin-Huei Chen specializes in the treatment of diabetes, obesity, osteoporosis, and other endocrine and metabolic disorders. From 2019 to 2021, Dr. Chen furthered her expertise through advanced training at the Cedars-Sinai Medical Center in the laboratory of Professor Shlomo Melmed. Her expertise also includes the diagnosis and treatment of thyroid diseases. She is proficient in performing thyroid ultrasound and specializes in minimally invasive thyroid ablation procedures, which effectively reduce thyroid nodules and minimize surgical wounds, significantly improving patients' quality of life. Moreover, Dr. Chen is deeply committed to providing endocrine treatment for transgender individuals, assisting them with gender-affirming hormone therapy.

Chen-Yuan Lin, M.D., Ph.D., is a physician in the Hematology and Oncology Department at China Medical University Hospital. He specializes in treating various cancers, particularly esophageal cancer, and leads multiple clinical trials. He is responsible for teaching and mentoring physicians and pharmacists, with a research focus on the tumor immune microenvironment and personalized tumor antigens. Leveraging his experience with high-dose interleukin-2 and immune checkpoint inhibitors, Dr. Lin is dedicated to enhancing the precision of immunotherapy and developing more effective cancer treatment strategies.targeting cancer cells and ultimately achieving more precise treatment outcomes.

Dr. Hsieh Ching-Yun is an attending physician in Hematology and Oncology at the China Medical University Hospital. Dr. Hsieh’s clinical research interests mainly focus on brain tumors, head and neck cancers, and lymphoma. He has participated in numerous international clinical trials related to these diseases and has also led two investigator-initiated clinical trials. Dr. Hsieh is highly active in early-phase clinical trials for anti-cancer drugs, having been involved in numerous anti-cancer drug clinical trials. Additionally, he participated in two Phase I clinical trials for intra-tumoral drug injections.

Dr. Ching-Chan Lin received his MD degree and PhD from China Medical University. He has served as an attending physician in the Division of Hematology and Oncology at China Medical University Hospital since 2010. He specializes in genitourinary cancers, hematologic malignancies, and hematopoietic stem cell transplantation. He is a member of the Taiwan Society of Internal Medicine, Chinese Society of Hematology, Chinese Society of Blood and Bone Marrow Transplantation, and Chinese Society of Oncology.

Hematologic malignancy, bone marrow transplantation
Breast cancer

Currently serving as an attending physician in the Division of Hematology and Oncology at China Medical University Hospital, with a medical degree from National Yang-Ming University. Specializes in hematologic diseases and malignancies such as leukemia, lymphoma, and multiple myeloma, with extensive experience in cancer treatment, particularly colorectal cancer and urological tumors. Formerly a research physician in hematology-oncology, dedicated to integrating clinical expertise with innovative therapies to provide personalized, high-quality care for patients.

Dr. Ming-Yu Lien, an attending physician at China Medical University Hospital's Hema-Oncology Department, is a Ph.D. holder and associate professor specializing in head and neck, nasopharyngeal, and esophageal cancers. As Vice Secretary-General of the Taiwan Head and Neck Society in 2024, he frequently speaks at major conferences and leads numerous clinical trials, highlighting his leadership in academia and clinical research.

Dr. Tzu-Ting Chen graduated from China Medical University School of Medicine and completed her residency training at China Medical University Hospital. She has served as an attending physician in the Division of Hematology and Oncology since 2014, and as the Director of Blood Bank since 2021. She specializes in hematologic malignancy treatment and hematopoietic stem cell transplantation, and is a member of the Taiwan Society of Internal Medicine, Chinese Society of Hematology, Oncology, and Blood and Marrow Transplantation.

Chi-Ching Chen, M.D., is currently the attending physician of the division of Hematology and Oncology at China Medical University Hospital. He completed his hematology and oncology training at the China Medical University Hospital, Taiwan. He is currently pursuing a Ph.D program for aging. Dr. Chen possesses extensive experience in the diagnosis and treatment of various malignant tumors and hematological diseases. He specializes in gastrointestinal cancers (esophagus, stomach, biliary tract, pancreas and colon), blood diseases, leukemia and hematopoietic stem cell transplantation. He follows a patient-centered, multi-specialty team care model and is committed to providing patients with personalized and high-quality medical care.